Hanover (THG) Officer Reports 17.513 RSUs Granted Under 2022 LTIP
Rhea-AI Filing Summary
Hanover Insurance Group (THG) officer Dennis Francis Kerrigan reported a non‑derivative acquisition on 09/26/2025 of 17.513 shares in the form of restricted stock units (RSUs) granted under the company's 2022 Long‑Term Incentive Plan at a $0 price. The filing shows Mr. Kerrigan is an Executive Vice President and the transaction increases his total beneficial ownership to 10,065.273 shares, which includes 33.525 shares acquired the same day under a dividend reinvestment plan exempt from Rule 16a‑11.
The RSUs relate to dividend equivalent rights tied to RSUs previously granted and will vest on the third anniversary of the original grant date. The form was submitted via a confirming statement filed 09/30/2025.
Positive
- Equity alignment: RSUs reinforce management ownership and align interests with shareholders
- No cash outlay: Grant recorded at $0 indicates an equity award rather than a purchase, preserving executive liquidity
Negative
- None.
Insights
TL;DR: Routine equity compensation grant to an executive; minimal immediate cash impact and modest change in ownership.
The Form 4 documents a standard RSU grant and the vesting of dividend equivalents rather than a market purchase. The grant price of $0 and the small share increment (17.513 shares) indicate an award tied to prior compensation arrangements rather than a new cash investment. The total reported beneficial ownership of 10,065.273 shares shows continued equity alignment between the officer and shareholders, but the transaction size appears immaterial to company capitalization.
TL;DR: Disclosure reflects routine executive compensation mechanics and compliance with Section 16 reporting requirements.
The filing clearly identifies the reporting person, relationship to the issuer, and the nature of the award: RSUs issued under the 2022 LTIP as accruals of dividend equivalents with a three‑year vesting schedule. Inclusion of dividend reinvestment plan shares and the confirming statement signature meet disclosure norms. No departures, options exercises, or unusual transfers are disclosed.